Shanghai, China

Jinglai Hao

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 10.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovator Spotlight: Jinglai Hao

Introduction

Jinglai Hao, a talented inventor in the vibrant city of Shanghai, CN, has made significant contributions to the field of pharmaceuticals with his innovative patent creations.

Latest Patents

Among his impressive portfolio of 6 patents, Jinglai Hao's latest inventions stand out. One of his patents involves hydroxy isoxazole compounds that are specifically useful as GPR120 agonists. These compounds offer promising potential for treating various health conditions such as diabetes, hyperlipidemia, obesity, NASH, and inflammation-related disorders, serving as agonists of the G-protein coupled receptor GPR120. Additionally, his Hepatitis C virus inhibitors patent showcases his dedication to developing treatments for HCV infections.

Career Highlights

Currently employed at Merck Sharp & Dohme Corporation, Jinglai Hao continues to excel in his role, contributing groundbreaking ideas and solutions in the pharmaceutical industry.

Collaborations

In his professional journey, Jinglai Hao has collaborated with esteemed coworkers such as Bin Hu and Joseph A Kozlowski, fostering a dynamic and innovative work environment at Merck Sharp & Dohme Corporation.

Conclusion

Jinglai Hao's relentless pursuit of innovation and his impressive patent portfolio demonstrate his profound impact on the field of pharmaceuticals. His contributions pave the way for advanced treatments and solutions, showcasing his remarkable talent and dedication to improving healthcare outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…